ResearcherKōchi UniversityNo recent work listed
Shigehiro Tsujii
Matched on OpenAlex author ID A5090565006. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2020: 1 paper · 2021: 2 papers
Papers 3
- A glypican-1-targeted antibody-drug conjugate exhibits potent tumor growth inhibition in glypican-1-positive pancreatic cancer and esophageal squamous cell car… Co-author DOI 10.1016/j.neo.2021.07.006↗
- Glypican-1 Is a Novel Target for Stroma and Tumor Cell Dual-Targeting Antibody-Drug Conjugates in Pancreatic Cancer. Co-author DOI 10.1158/1535-7163.mct-21-0335↗
- Anti-glypican-1 antibody-drug conjugate is a potential therapy against pancreatic cancer. Co-author DOI 10.1038/s41416-020-0781-2↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Tetsuji Naka · 3 shared papers, 2020–2021 · strength 0.33
- Paper Glypican-1 Is a Novel Target for Stroma and Tumor Cell Dual-Targeting Antibody-Drug Conjugates in Pancreatic Cancer. DOI 10.1158/1535-7163.mct-21-0335↗
- Paper A glypican-1-targeted antibody-drug conjugate exhibits potent tumor growth inhibition in glypican-1-positive pancreatic… DOI 10.1016/j.neo.2021.07.006↗
- Paper Anti-glypican-1 antibody-drug conjugate is a potential therapy against pancreatic cancer. DOI 10.1038/s41416-020-0781-2↗
- Sunao Uemura · 2 shared papers, 2021 · strength 0.25
- Paper Glypican-1 Is a Novel Target for Stroma and Tumor Cell Dual-Targeting Antibody-Drug Conjugates in Pancreatic Cancer. DOI 10.1158/1535-7163.mct-21-0335↗
- Paper A glypican-1-targeted antibody-drug conjugate exhibits potent tumor growth inhibition in glypican-1-positive pancreatic… DOI 10.1016/j.neo.2021.07.006↗
- Kazuhiro Hanazaki · 2 shared papers, 2021 · strength 0.25
- Paper Glypican-1 Is a Novel Target for Stroma and Tumor Cell Dual-Targeting Antibody-Drug Conjugates in Pancreatic Cancer. DOI 10.1158/1535-7163.mct-21-0335↗
- Paper A glypican-1-targeted antibody-drug conjugate exhibits potent tumor growth inhibition in glypican-1-positive pancreatic… DOI 10.1016/j.neo.2021.07.006↗
- Eri Munekage · 1 shared paper, 2021 · strength 0.11
- Takahiko Nishigaki · 1 shared paper, 2020 · strength 0.08
- Masaki Mori · 1 shared paper, 2020 · strength 0.08
- Yuichiro Doki · 1 shared paper, 2020 · strength 0.08
- Toru Otsuru · 1 shared paper, 2020 · strength 0.08
- Hidetoshi Eguchi · 1 shared paper, 2020 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.